Thomas B. Neff

Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis

Nan Chen, Chuan‐Ming Hao, Bi‐Cheng Liu et al. · New England Journal of Medicine · 2019 · 613 citations

Medicine, Hematology, Pharmacotherapy +15

Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis

Nan Chen, Chuan‐Ming Hao, Xiaomei Peng et al. · New England Journal of Medicine · 2019 · 568 citations · Full text

Medicine, Hematology, Pharmacotherapy +17

Oral Hypoxia–Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for the Treatment of Anemia in Patients with CKD

Robert Provenzano, Anatole Besarab, Chao Sun et al. · Clinical Journal of the American Society of Nephrology · 2016 · 293 citations · Full text

Medicine, Hematology, Pharmacotherapy +14

Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trial

Luca Richeldi, Evans R. Fernández Pérez, Ulrich Costabel et al. · The Lancet Respiratory Medicine · 2019 · 286 citations

Medicine, Clinical Sciences, Pharmacotherapy +13

Randomized placebo-controlled dose-ranging and pharmacodynamics study of roxadustat (FG-4592) to treat anemia in nondialysis-dependent chronic kidney disease (NDD-CKD) patients

Anatole Besarab, Robert Provenzano, Joachim Hertel et al. · Nephrology Dialysis Transplantation · 2015 · 279 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13